NCT04072107 2023-06-18
EP-STAR
Sun Yat-sen University
Phase 2 Unknown
Clinical Trials
11 trialsNCT05749042 2023-03-01
A Study of Concurrent Chemoradiotherapy Based of Cisplatin With or Without Sintilimab as First-line Therapy for Patients With Advanced Oral Cavity Squamous Cell Carcinoma
China Three Gorges University, Yichang, China
Phase 2 Unknown
NCT04872582 2023-02-23
Efficacy and Safety of Sintilimab Plus Bevacizumab in Metastatic Nasopharyngeal Carcinoma After Failure of Platinum-based Chemotherapy: An Open-label Phase II Study
Sun Yat-sen University
Phase 2 Unknown
NCT05201859 2022-05-06
Adjuvant Sintilimab Plus Capecitabine in Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 2 Unknown
NCT05136768 2021-11-29
LM-HNSCC
ChineseAMS
Phase 2 Unknown
NCT04917770 2021-06-08
The Efficacy and Safety of Sintilimab in Combination With Multimodal Radiotherapy in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma
West China Hospital
Phase 2 Unknown
NCT04882462 2021-05-12
Carpp-1
The First Affiliated Hospital of Soochow University
Phase 2 Unknown
NCT04769076 2021-02-25
The Paclitaxel (Albumin-bound) Combined With Cisplatin, PD-1 Inhibitors and IMRT in the Treatment of Nasopharyngeal Carcinoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2 Unknown
NCT04065737 2019-08-22
STOP
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2 Unknown
NCT03975270 2019-07-18
HNSCC
ChineseAMS
Phase 2 Unknown
NCT03619824 2018-10-09
PD-1 Blockade Combined With Definitive Chemoradiation in Locoregionally-advanced Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 2 Unknown